The Cooper Companies, Inc. (NASDAQ:COO) Receives Average Rating of “Hold” from Brokerages

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have been assigned a consensus rating of “Hold” from the seventeen brokerages that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, six have issued a hold recommendation, seven have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $81.3571.

A number of research analysts have recently issued reports on COO shares. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research note on Wednesday, May 27th. Wells Fargo & Company restated a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. JPMorgan Chase & Co. cut their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a report on Friday, June 5th. Finally, Citigroup restated a “neutral” rating and issued a $76.00 price objective (up from $69.00) on shares of Cooper Companies in a research report on Wednesday, July 8th.

Cooper Companies Trading Down 2.0%

Shares of COO stock opened at $73.32 on Friday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The firm has a market cap of $14.30 billion, a P/E ratio of 62.14, a PEG ratio of 1.96 and a beta of 0.83. The company has a 50 day moving average of $69.37 and a 200-day moving average of $71.49. Cooper Companies has a 12-month low of $58.89 and a 12-month high of $89.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts anticipate that Cooper Companies will post 4.63 earnings per share for the current year.

Institutional Trading of Cooper Companies

Large investors have recently bought and sold shares of the company. State Street Corp lifted its position in Cooper Companies by 2.4% during the 4th quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after acquiring an additional 207,195 shares during the period. Wellington Management Group LLP grew its stake in shares of Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Cooper Companies by 58.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after buying an additional 2,231,568 shares during the last quarter. Sustainable Growth Advisers LP raised its stake in Cooper Companies by 22.1% during the third quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock valued at $283,327,000 after buying an additional 747,476 shares during the last quarter. Finally, Franklin Resources Inc. grew its stake in shares of Cooper Companies by 108.2% in the fourth quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock worth $329,646,000 after acquiring an additional 2,089,763 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.